119 related articles for article (PubMed ID: 8283174)
1. Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5'-nontranslated region does not contain major attenuation determinants.
Zhang HY; Yousef GE; Cunningham L; Blake NW; OuYang X; Bayston TA; Kandolf R; Archard LC
J Med Virol; 1993 Oct; 41(2):129-37. PubMed ID: 8283174
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.
Zhang H; Blake NW; Ouyang X; Pandolfino YA; Morgan-Capner P; Archard LC
Arch Virol; 1995; 140(5):959-66. PubMed ID: 7605207
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
Zhang H; Yousef GE; Ouyang X; Archard LC
Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
[TBL] [Abstract][Full Text] [Related]
4. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.
Dunn JJ; Chapman NM; Tracy S; Romero JR
J Virol; 2000 May; 74(10):4787-94. PubMed ID: 10775617
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.
Zhang H; Morgan-Capner P; Latif N; Pandolfino YA; Fan W; Dunn MJ; Archard LC
Am J Pathol; 1997 Jun; 150(6):2197-207. PubMed ID: 9176409
[TBL] [Abstract][Full Text] [Related]
6. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.
Tu Z; Chapman NM; Hufnagel G; Tracy S; Romero JR; Barry WH; Zhao L; Currey K; Shapiro B
J Virol; 1995 Aug; 69(8):4607-18. PubMed ID: 7609025
[TBL] [Abstract][Full Text] [Related]
7. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.
Chapman NM; Tu Z; Tracy S; Gauntt CJ
Arch Virol; 1994; 135(1-2):115-30. PubMed ID: 8198437
[TBL] [Abstract][Full Text] [Related]
8. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B3 clinical isolates and murine myocarditis.
Gauntt CJ; Pallansch MA
Virus Res; 1996 Mar; 41(1):89-99. PubMed ID: 8725105
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of genomic RNA of Coxsackievirus B3 in murine myocarditis: reliability of direct sequencing of reverse transcription-nested polymerase chain reaction products.
Zhang H; Soteriou B; Knowlson S; Theodoridou A; Archard LC
J Virol Methods; 1997 Dec; 69(1-2):7-17. PubMed ID: 9504746
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: assessment of candidate mutations by analysis of a revertant to cardiovirulence.
Cameron-Wilson CL; Pandolfino YA; Zhang HY; Pozzeto B; Archard LC
Clin Diagn Virol; 1998 Apr; 9(2-3):99-105. PubMed ID: 9645991
[TBL] [Abstract][Full Text] [Related]
12. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
13. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
Lee C; Maull E; Chapman N; Tracy S; Gauntt C
J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.
Lee CK; Kono K; Haas E; Kim KS; Drescher KM; Chapman NM; Tracy S
J Gen Virol; 2005 Jan; 86(Pt 1):197-210. PubMed ID: 15604447
[TBL] [Abstract][Full Text] [Related]
15. Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs.
Lee C; Maull E; Chapman N; Tracy S; Wood J; Gauntt C
Virus Res; 1997 Aug; 50(2):225-35. PubMed ID: 9282787
[TBL] [Abstract][Full Text] [Related]
16. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.
Stadnick E; Dan M; Sadeghi A; Chantler JK
J Virol; 2004 Dec; 78(24):13987-4002. PubMed ID: 15564506
[TBL] [Abstract][Full Text] [Related]
17. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice.
Tracy S; Chapman NM; Tu Z
Arch Virol; 1992; 122(3-4):399-409. PubMed ID: 1310000
[TBL] [Abstract][Full Text] [Related]
19. Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3.
Chapman NM; Romero JR; Pallansch MA; Tracy S
J Med Virol; 1997 Jul; 52(3):258-61. PubMed ID: 9210033
[TBL] [Abstract][Full Text] [Related]
20. Genetics of coxsackievirus B3 cardiovirulence.
Tracy S; Tu Z; Chapman N; Hufnagel G
Eur Heart J; 1995 Dec; 16 Suppl O():15-7. PubMed ID: 8682085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
